1. McSteen, B. W.; Ying, X. H.; Lucero, C.; Jesudian, A. B. Viral etiologies of acute liver failure. World J Virol. 2024, 13, 97973.2. Devarbhavi, H.; Asrani, S. K.; Arab, J. P.; Nartey, Y. A.; Pose, E.; Kamath, P. S. Global burden of liver disease: 2023 update. J Hepatol. 2023, 79, 516 - 537.3. Tadokoro, T.; Murata, S.; Kato, M.; Ueno, Y.; Tsuchida, T.; Okumura, A.; Kuse, Y.; Konno, T.; Uchida, Y.; Yamakawa, Y.; Zushi, M.; Yajima, M.; Kobayashi, T.; Hasegawa, S.; Kawakatsu - Hatada, Y.; Hayashi, Y.; Osakabe, S.; Maeda, T.; Kimura, K.; Mori, A.; Tanaka, M.; Kamishibahara, Y.; Matsuo, M.; Nie, Y. Z.; Okamoto, S.; Oba, T.; Tanimizu, N.; Taniguchi, H. Human iPSC - liver organoid transplantation reduces fibrosis through immunomodulation. Sci TranslMed. 2024, 16, eadg0338.4. Liu, Q.; Wang, S.; Fu, J.; Chen, Y.; Xu, J.; Wei, W.; Song, H.; Zhao, X.; Wang, H. Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations. Clin Transl Med. 2024, 14, e1812.5. Zhang, K.; Zhang, L.; Liu, W.; Ma, X.; Cen, J.; Sun, Z.; Wang, C.; Feng, S.; Zhang, Z.; Yue, L.; Sun, L.; Zhu, Z.; Chen, X.; Feng, A.; Wu, J.; Jiang, Z.; Li, P.; Cheng, X.; Gao, D.; Peng, L.; Hui, L. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell. 2018, 23, 806 - 819.e4.6. Fu, G. B.; Huang, W. J.; Zeng, M.; Zhou, X.; Wu, H. P.; Liu, C. C.; Wu, H.; Weng, J.; Zhang, H. D.; Cai, Y. C.; Ashton, C.; Ding, M.; Tang, D.; Zhang, B. H.; Gao, Y.; Yu, W. F.; Zhai, B.; He, Z. Y.; Wang, H. Y.; Yan, H. X. Expansion and differentiation of human hepatocyte - derived liver progenitor - like cells and their use for the study of hepatotropic pathogens. Cell Res. 2019, 29, 8 - 22.7. Yuan, X.; Wu, J.; Sun, Z.; Cen, J.; Shu, Y.; Wang, C.; Li, H.; Lin, D.; Zhang, K.; Wu, B.; Dhawan, A.; Zhang, L.; Hui, L. Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure. Cell Stem Cell. 2024, 31, 484 - 498.e5.8. Lee, K. Y.; Mooney, D. J. Alginate: properties and biomedical applications. Prog Polym Sci. 2012, 37, 106 - 126.9. Lopez - Mendez, T. B.; Santos - Vizcaino, E.; Pedraz, J. L.; Hernandez, R. M.; Orive, G. Cell microencapsulation technologies for sustained drug delivery: Clinical trials and companies. Drug Discov Today. 2021, 26, 852 - 861.10. Dhawan, A.; Chaijitraruch, N.; Fitzpatrick, E.; Bansal, S.; Filippi, C.; Lehec, S. C.; Heaton, N. D.; Kane, P.; Verma, A.; Hughes, R. D.; Mitry, R. R. Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children. J Hepatol. 2020, 72, 877 - 884.11. Fitzpatrick, E.; Filippi, C.; Jagadisan, B.; Shivapatham, D.; Anand, H.; Lyne, M.; Stroud, K. D.; Newton, R.; DeLord, M.; Douiri, A.; Dhawan, A. Intraperitoneal transplant of Hepatocytes co - Encapsulated with mesenchymal stromal cells in modified alginate microbeads for the treatment of acute liver failure in pediatric patients (HELP) - an open - label, single - arm Simon’s two stage phase 1 study protocol. PLoS One. 2023, 18, e0288185.12. Kang, A.; Park, J.; Ju, J.; Jeong, G. S.; Lee, S. H. Cell encapsulation via microtechnologies. Biomaterials. 2014, 35, 2651 - 2663.